Univariate analysis | Â | RC (%) | LC (%) | DMFS (%) | DFS (%) | OS (%) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Variable | N | 5-year | P | 5-year | P | 5-year | P | 5-year | P | 5-year | P |
N stage | |||||||||||
 pN+ | 18 | 49.6 | 0.002 | 75.0 | 0.015 | 31.1 | < 0.001 | 24.5 | < 0.001 | 37.5 | < 0.001 |
 pN0 & cN0/pNxa | 47 | 87.7 |  | 100 |  | 77.5 |  | 77.8 |  | 85.2 |  |
Extranodal extension | |||||||||||
 Yes | 12 | 55.4 | 0.004 | 83.3 | 0.149 | 21.2 | < 0.001 | 21.8 | < 0.001 | 30.0 | < 0.001 |
 No | 53 | 84.2 |  | 97.3 |  | 74.2 |  | 72.0 |  | 81.0 |  |
T stage | |||||||||||
 pT3–4 | 26 | 57.9 | < 0.001 | 93.8 | 0.104 | 33.2 | < 0.001 | 35.1 | < 0.001 | 45.9 | < 0.001 |
 pT1–2 | 39 | 93.1 |  | 96.7 |  | 85.5 |  | 82.2 |  | 88.9 |  |
Lymphovascular invasion | |||||||||||
 Yes | 15 | 51.0 | < 0.001 | 90.0 | 0.569 | 29.6 | < 0.001 | 30.5 | < 0.001 | 44.4 | < 0.001 |
 No | 50 | 89.4 |  | 96.9 |  | 78.6 |  | 75.0 |  | 82.7 |  |
Perineural invasion | |||||||||||
 Yes | 35 | 66.2 | 0.007 | 92.0 | 0.084 | 48.9 | 0.002 | 45.7 | 0.001 | 66.3 | 0.092 |
 No | 30 | 95.7 |  | 100 |  | 87.9 |  | 87.9 |  | 78.0 |  |
Margin < 1 mm | |||||||||||
 Yes | 47 | 79.1 | 0.910 | 96.6 | 0.794 | 68.7 | 0.418 | 66.0 | 0.449 | 75.7 | 0.475 |
 No | 18 | 80.9 |  | 91.7 |  | 57.0 |  | 57.5 |  | 61.1 |  |
High-grade histology | |||||||||||
 Yes | 59 | 77.1 | 0.204 | 94.9 | 0.466 | 63.0 | 0.324 | 61.3 | 0.287 | 68.4 | 0.079 |
 No | 6 | 100 |  | 100 |  | 85.7 |  | 85.7 |  | 100 |  |
Multivariate analysis | |||||||||||
Variable | HR | 95% CI | P | Variable | HR | 95% CI | P | ||||
Regional control | Disease-free survival | ||||||||||
 T stage (pT3–4 vs pT1–2) | 8.129 | 1.661–39.779 | 0.010 |  N stage (pN+ vs pN0 & cN0/pNxa) | 4.026 | 1.464–11.075 | 0.007 | ||||
 Lymphovascular invasion (Yes vs No) | 4.130 | 1.165–14.643 | 0.028 |  Perineural invasion (Yes vs No) | 5.377 | 1.512–19.121 | 0.009 | ||||
Local control | – | – | NS |  T stage (pT3–4 vs pT1–2) | 3.762 | 1.262–11.213 | 0.017 | ||||
Distant metastasis-free survival | Overall survival | ||||||||||
 T stage (pT3–4 vs pT1–2) | 5.171 | 1.715–15.591 | 0.004 |  N stage (pN+ vs pN0 & cN0/pNxa) | 4.363 | 1.710–11.127 | 0.002 | ||||
 Perineural invasion (Yes vs No) | 4.337 | 1.234–15.236 | 0.022 |  T stage (pT3–4 vs pT1–2) | 4.841 | 1.671–14.020 | 0.004 | ||||
 Lymphovascular invasion (Yes vs No) | 2.719 | 1.065–6.942 | 0.037 |  |  |  |  |